U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
123811123811Evaluation of Early Bactericidal Activity in Pulmonary TuberculosisCompletedNo Results AvailablePulmonary TuberculosisDrug: PA-824|Drug: PA-824|Drug: PA-824|Drug: Rifafour e-275 mg|Drug: PA-824https://ClinicalTrials.gov/show/NCT00944021
123812123812PROCEDYTE: Depocyte® Administration (Liposomal Cytarabine) as Prophylaxis of Neuromeningeal Infiltration in Acute Lymphoblastic LeukemiaTerminatedNo Results AvailableAcute Lymphoblastic LeukemiaDrug: DepoCytehttps://ClinicalTrials.gov/show/NCT00944008
123813123813Three Times Weekly (TIW) Growth Hormone Therapy in Children on HemodialysisCompletedNo Results AvailableKidney Failure, Chronic|Renal DialysisDrug: somatropinhttps://ClinicalTrials.gov/show/NCT00943995
123814123814The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon GammaCompletedNo Results AvailableUveitisDrug: Interferon Gamma 1-bhttps://ClinicalTrials.gov/show/NCT00943982
123815123815Determinants of Oral Morphine Answer Among Obese Patients Before and After Gastric BypassRecruitingNo Results AvailableObesityProcedure: gastric bypasshttps://ClinicalTrials.gov/show/NCT00943969
123816123816Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate CancerCompletedNo Results AvailableProstate CancerDrug: bicalutamide|Drug: everolimus|Drug: leuprolide acetate|Radiation: external beam radiation therapyhttps://ClinicalTrials.gov/show/NCT00943956
123817123817Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 MutationsActive, not recruitingNo Results AvailableAcute Myelogenous Leukemia|LeukemiaDrug: G-CSF|Drug: Plerixafor|Drug: Sorafenibhttps://ClinicalTrials.gov/show/NCT00943943
123818123818Marijuana Drug Discrimination and Self-AdministrationCompletedNo Results AvailableMarijuana AbuseDrug: THC (delta-9 tetrahydrocannabinol), d-amphetamine, oral THChttps://ClinicalTrials.gov/show/NCT00943930
123819123819Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes MellitusCompletedHas ResultsType 2 DiabetesOther: ITCA 650|Drug: Exenatide Injection|Other: Ex Inj/ITCA 650https://ClinicalTrials.gov/show/NCT00943917
123820123820Comparison of Motor and Sensory Response With Interstim StimulationCompletedNo Results AvailableOveractive Bladder|Urgency-FrequencyDevice: Interstim implant for SNShttps://ClinicalTrials.gov/show/NCT00943904
123821123821A Study of Lymphangiogenesis in Colorectal and Nasopharyngeal CancerActive, not recruitingNo Results AvailableColorectal Cancer|Nasopharyngeal CancerProcedure: Tumor biopsieshttps://ClinicalTrials.gov/show/NCT00943891
123822123822Sanofi H1N1 + TIV - Adults and ElderlyCompletedHas ResultsInfluenzaBiological: Trivalent inactivated influenza vaccine|Biological: Inactivated H1N1 Vaccine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00943878
123823123823Three Lifestyle Interventions on Endothelial Function and Cardiometabolic Risk in Obese Patients With Metabolic SyndromeCompletedNo Results AvailableMetabolic Syndrome|ObesityBehavioral: hypocaloric diet|Behavioral: Exercise recommendations|Behavioral: Pragmatic diet|Behavioral: Pedometer-based fitness (10,000 steps)|Behavioral: Structured assisted exercise (fitness)https://ClinicalTrials.gov/show/NCT00943865
123824123824The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)CompletedHas ResultsHypertensionDrug: losartan potassium|Drug: Comparator: isosorbide mononitrate (ISMN)|Drug: Comparator: losartan + ISMN|Drug: Comparator: losartan + ISMN|Drug: Comparator: Placebohttps://ClinicalTrials.gov/show/NCT00943852
123825123825Sunitinib Malate in Treating Patients With Kidney CancerRecruitingNo Results AvailableKidney CancerDrug: sunitinib malate|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00943839
123826123826A Study of Avastin® (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GlioblastomaActive, not recruitingHas ResultsGlioblastomaDrug: bevacizumab [Avastin®]|Drug: Placebo|Drug: temozolomide|Radiation: Radiation therapyhttps://ClinicalTrials.gov/show/NCT00943826
123827123827Assessment of Comskil Training Through Videorecording and Patient SurveysActive, not recruitingNo Results AvailableComskil TrainingBehavioral: video-recording and completing a surveyhttps://ClinicalTrials.gov/show/NCT00943813
123828123828Combined Haploidentical-Cord Blood Transplantation for Adults and ChildrenActive, not recruitingNo Results AvailableLeukemia|Myelodysplastic Syndrome|Multiple Myeloma|LymphomaDrug: Fludarabine-Melphalan & Rabbit antithymocyte globulin (r-ATG)|Procedure: Stem Cell Transplant|Procedure: Stem Cells Collections|Drug: Fludarabine, Thiotepa, Antithymocyte globulin (ATG), and Total Body Irradiation (TBI)|Drug: Fludarabine, Busulfan, and ATGhttps://ClinicalTrials.gov/show/NCT00943800
123829123829Counter-Regulatory Impairment and the Effect of Microvascular Insulin Transfer in Type 1 Diabetes MellitusCompletedHas ResultsDiabetes Mellitus, Type 1Procedure: Hyperinsulinemic, euglycemic and hypoglycemic clamphttps://ClinicalTrials.gov/show/NCT00943787
123830123830High Resolution Phenotyping in Healthy HumansCompletedNo Results AvailablePressor Response|Baroreflex Sensitivity|Blood Pressure Variability|Heart Rate Variability|Arterial CatecholaminesOther: Physiological maneuvershttps://ClinicalTrials.gov/show/NCT00943774
123831123831A Study of Vaniprevir (MK-7009) in Participants With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028)CompletedHas ResultsHepatitis C, ChronicDrug: Vaniprevir 600 mg b.i.d.|Drug: Vaniprevir 300 mg b.i.d.|Drug: Pegylated interferon|Drug: Ribavirinhttps://ClinicalTrials.gov/show/NCT00943761
123832123832Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's DiseaseCompletedNo Results AvailableParkinson's DiseaseDrug: deferiprone|Drug: placebohttps://ClinicalTrials.gov/show/NCT00943748
123833123833This Is An Open-Label Study To Evaluate Fesoterodine Plus "Your Way" Patient Support Plan In Patients With Symptoms Of Overactive BladderCompletedHas ResultsOveractive BladderDrug: Fesoterodine|Behavioral: Your Wayhttps://ClinicalTrials.gov/show/NCT00943735
123834123834A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)Active, not recruitingHas ResultsCervical Cancers|Vulvar Cancer|Vaginal Cancer|Genital Lesions|PAP Test Abnormalities|HPV InfectionsBiological: V503https://ClinicalTrials.gov/show/NCT00943722
123835123835Intensive Glycemic Control on Infectious Morbidity In Patients With Acute LeukemiaWithdrawnNo Results AvailableHyperglycemia|LeukemiaBiological: insulin glargine recombinant|Drug: therapeutic insulinhttps://ClinicalTrials.gov/show/NCT00943709
123836123836Effects of White Wine vs. Tea Intake During and an Alcoholic Digestive Following a High Fat, High Calorie Cheese Fondue Meal on Gastric Emptying and Abdominal Symptoms in Healthy VolunteersCompletedNo Results AvailableHealthy ParticipantsDietary Supplement: Ingestion of white wine vs. tea during and an alcohttps://ClinicalTrials.gov/show/NCT00943696
123837123837Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)CompletedHas ResultsAsthmaDrug: montelukast sodium|Drug: Comparator: Placebohttps://ClinicalTrials.gov/show/NCT00943683
123838123838Corrected QT Interval Effects of Trastuzumab Emtansine (T-DM1) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer and the Safety and Tolerability of Combined T-DM1 and Pertuzumab in PatieCompletedHas ResultsMetastatic Breast CancerBiological: pertuzumab|Biological: Trastuzumab emtansine [Kadcyla]https://ClinicalTrials.gov/show/NCT00943670
123839123839Yearly Strain Variation Study, 2009/2010CompletedNo Results AvailableInfluenza|Seasonal InfluenzaBiological: Preflucel [Trivalent seasonal influenza vaccine (split virus, Vero cell-derived)]https://ClinicalTrials.gov/show/NCT00943657
123840123840Pre-biopsy With Dynamic AcquisitionsCompletedNo Results AvailableBreast CancerDevice: Molecular Breast Imaging (MBI)|Device: CZT semiconductor detectorshttps://ClinicalTrials.gov/show/NCT00943644

* Görseller ve İçerik tekif hakkına sahip olabilir